BDX - Embecta submits FDA application for type 2 diabetes insulin patch pump
2024-01-09 13:05:55 ET
More on Embecta
- Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript
- Embattled Embecta Continues To Present Challenges To Shareholder Value
- Embecta Non-GAAP EPS of $0.59 beats by $0.19, revenue of $281.9M beats by $10.35M
- Seeking Alpha’s Quant Rating on Embecta
- Historical earnings data for Embecta
For further details see:
Embecta submits FDA application for type 2 diabetes insulin patch pump